These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22116776)

  • 1. Girdin protein: a new potential distant metastasis predictor of breast cancer.
    Liu C; Zhang Y; Xu H; Zhang R; Li H; Lu P; Jin F
    Med Oncol; 2012 Sep; 29(3):1554-60. PubMed ID: 22116776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell gene Girdin: a potential early liver metastasis predictor of colorectal cancer.
    Liu C; Xue H; Lu Y; Chi B
    Mol Biol Rep; 2012 Sep; 39(9):8717-22. PubMed ID: 22714912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications for girdin protein expression in breast cancer.
    Ling Y; Jiang P; Cui SP; Ren YL; Zhu SN; Yang JP; Du J; Zhang Y; Liu JY; Zhang B
    Cancer Invest; 2011 Jul; 29(6):405-10. PubMed ID: 21649466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of cytoplasmic and nuclear girdin expression is an independent prognosis factor of breast cancer.
    Zhang H; Yu F; Qin F; Shao Y; Chong W; Guo Z; Liu X; Fu L; Gu F; Ma Y
    FASEB J; 2018 May; 32(5):2395-2410. PubMed ID: 29259035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.
    Choi JS; Kim KH; Oh E; Shin YK; Seo J; Kim SH; Park S; Choi YL
    Pathology; 2017 Oct; 49(6):618-626. PubMed ID: 28818465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of phosphorylated Girdin in breast cancer].
    Xu Y; Fu L; Gu F; Ma YJ
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):205-9. PubMed ID: 22780975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of Girdin in the nucleus indicates worse prognosis for patients with estrogen receptor-positive breast cancer.
    Peng WT; Hu X; Yao L; Jiang YZ; Shao ZM
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S648-56. PubMed ID: 24793340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Girdin correlated with autophagy in invasive ductal breast carcinomas.
    Jiang P; Cui SP; Ren YL; Mao JZ; Liu HJ; Tian Y; Liu JY; Du J; Hou L; Zhang B
    Tumori; 2013; 99(4):530-4. PubMed ID: 24326843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of Girdin expression on recurrence-free survival in patients with luminal-type breast cancer.
    Nishimae K; Tsunoda N; Yokoyama Y; Kokuryo T; Iwakoshi A; Takahashi M; Nagino M
    Breast Cancer; 2015 Sep; 22(5):445-51. PubMed ID: 24155038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of Girdin and PI3K protein expression in breast cancer.
    Jin F; Liu C; Guo Y; Chen H; Wu Y
    Oncol Lett; 2013 May; 5(5):1549-1553. PubMed ID: 23760650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of Girdin protein expression in glioma.
    Zhao L; Ma S; Liu Q; Liang P
    ScientificWorldJournal; 2013; 2013():986073. PubMed ID: 24288520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dephosphorylation of Girdin by PP2A inhibits breast cancer metastasis.
    Li J; Enomoto A; Weng L; Sun L; Takahashi M
    Biochem Biophys Res Commun; 2019 May; 513(1):28-34. PubMed ID: 30935690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of girdin in human colorectal cancer and its association with tumor progression.
    Jun BY; Kim SW; Jung CK; Cho YK; Lee IS; Choi MG; Choi KY; Oh ST
    Dis Colon Rectum; 2013 Jan; 56(1):51-7. PubMed ID: 23222280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).
    De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A
    BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEK: A novel early screening and prognostic marker for breast cancer.
    Ying G; Wu Y
    Mol Med Rep; 2015 Nov; 12(5):7491-5. PubMed ID: 26459608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.
    Min KW; Kim DH; Do SI; Chae SW; Kim K; Sohn JH; Pyo JS; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kim EK; Kwon MJ; Seo J; Moon KM
    Virchows Arch; 2016 Apr; 468(4):409-16. PubMed ID: 26719157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talen-mediated girdin knockout downregulates cell proliferation, migration and invasion in human esophageal carcinoma ECA109 cells.
    Cao K; Jiang W; Cao P; Zou Q; Xiao S; Zhou J; Huang C
    Mol Med Rep; 2014 Aug; 10(2):848-54. PubMed ID: 24865549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.
    Alford SH; Toy K; Merajver SD; Kleer CG
    Breast Cancer Res Treat; 2012 Apr; 132(2):429-37. PubMed ID: 21614565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.